19 August 2021 - final results
The AIM-listed specialist infection and control company has announced its final results for the year to 31 March 2021which have seen a significant increase over the previous year. This is hardly surprising given the nature of the group's business which has benefited significantly from the pandemic and the increase in demand for its products. Revenues for the year rose to £11.2m (2020: £6.0m) with adjusted pre-tax profits increasing to £1.0m (2020: £0.2m). Earnings per share on the same basis rose to 0.29p (2020: 0.11p). The company . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
